Jaguar Health, Inc. (JAGX): Submission of Matters to a Vote of Security Holders
Jaguar Health, Inc. (JAGX) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Exhibit 99.1 Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders San Francisco, CA (November 6, 2026): Jaguar Health, Inc. (NASDAQ: JAGX) (“Jaguar” or the “Company”) today announced the voting results of the Company’s November 6, 2026
How this was made
The 30-second read
Why it matters
The filing confirms routine governance actions; no new capital, M&A, or product news is presented.
Market read
Limited relevance; primarily of interest to existing shareholders and compliance monitors.
What to watch
Potential future actions stemming from the approved proposals are not disclosed.
Background
The article is an unedited SEC 8‑K press release announcing the results of a special shareholders' meeting for Jaguar Health, Inc.
Ticker impact
SEC 8‑K filing reports that shareholders approved six proposals at the November 6, 2026 special meeting.
no significant impact as the vote confirms existing governance actions
The filing contains only standard corporate governance approvals without new financing, acquisitions, or material operational changes.
Market effects
none
none
none
Counterpoint
If the proposals included hidden strategic shifts, the market could react, but the filing provides no such detail.
Key entities
- companyJaguar Health, Inc.
Biopharma company developing plant‑derived gastrointestinal drugs.
